No Caffeine — The Unstimulated CNS Baseline
Every dose-response curve starts from a true zero-caffeine baseline.
- 85%: Habitual caffeine users (US) (consume it daily)
- ~5 h: Average adult half-life (range 1.5–9.5 h)
- Baseline: Resting CNS arousal (no adenosine blockade)
- Unblocked: Adenosine receptors (normal fatigue signaling)
Adenosine and natural fatigue signaling
Adenosine builds up and quietly signals the brain to feel tired.
Why baseline matters for the curve
Every performance gain later is measured against this resting line.
Individual variability before any dose
Genetics already shape baseline alertness before caffeine enters at all.
Low Dose (1–3 mg/kg) — Mild Stimulation Onset
A small dose nudges alertness up with barely any downside risk.
- 70–210 mg: Typical low dose (70 kg) (about one cup coffee)
- +2–5%: Performance boost range (endurance tasks)
- Mild gain: Reaction time change (small but measurable)
- Minimal: Side-effect risk (rare mild jitteriness)
Adenosine receptor blockade begins
Caffeine starts occupying adenosine receptors, delaying the fatigue signal slightly.
Early performance and alertness gains
Vigilance and simple reaction time improve first, before strength or power.
Why low doses feel safest
Blockade is partial, so overstimulation and anxiety symptoms stay very rare.
Moderate Dose (3–6 mg/kg) — The Effective Zone
This range delivers the strongest reliable performance-per-milligram payoff.
- 210–420 mg: Typical moderate dose (70 kg) (roughly 2–4 cups)
- +5–12%: Performance boost range (peak efficiency zone)
- 3–6: ISSN recommended range (mg per kg bodyweight)
- Strong: Alertness gain (consistent across studies)
Peak receptor occupancy and output
Most adenosine receptors are now blocked, maximizing the alertness payoff.
Endurance and strength performance gains
Time-to-exhaustion, power output, and perceived exertion all improve together.
Why sport science favors this range
Most benefit arrives here, before side effects start eating into it.
High Dose (6–9 mg/kg) — Diminishing Returns
Extra milligrams buy little extra performance but much more jitteriness.
- 420–630 mg: Typical high dose (70 kg) (exceeds daily guidance)
- +3–8%: Performance boost range (plateaus or dips)
- Elevated: Jitteriness/anxiety risk (common above 6 mg/kg)
- 400 mg/day: FDA single-dose caution (general healthy-adult limit)
The curve bends over, then falls
Near-total receptor saturation means extra dose adds risk, not benefit.
Overstimulation undermines fine motor control
Tremor, racing heart, and anxiety can actively hurt skilled performance.
Where the safety margin narrows
GI distress, insomnia, and palpitations become noticeably more common here.
Chronic Daily Use — The Curve Flattens and Shifts
Regular use blunts the same dose into a smaller, later effect.
- Upregulates: Adenosine receptor count (brain adds more receptors)
- 1–4 days: Tolerance onset (of consistent daily dosing)
- ~40–60%: Performance benefit retained (after weeks of daily use)
- 1–2 wk: Recommended reset period (abstinence restores sensitivity)
Receptor upregulation drives tolerance
The brain grows more adenosine receptors to compensate for constant blockade.
Same dose, smaller and later effect
The curve's peak drops and shifts right, needing more for less.
Cycling and resetting sensitivity
A short break restores much of the original dose-response curve.